Experimental Survodutide Led to Weight Loss of as Much as 13.1% in Adults with Type 2 Diabetes in Boehringer's Phase 3 Study
An experimental once-weekly injection known as survodutide helped adults with obesity or overweight and type 2 diabetes lose as much as 13.1% of their body weight over 76 weeks,…
5 min read · Updated 2026-10-02